Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-029626

SVP and General Counsel sold 4,166 shares at $41.93 ($174,680)

  • SVP and General Counsel acquired 4,166 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Taylor Stacy L · SVP and General Counsel

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2021-04-30 Exercise or conversion : show line 1 in the form +1,042 $7.80 $8,128 16,078 D
2021-04-30 Exercise or conversion : show line 2 in the form +1,770 $6.55 $11,594 17,848 D
2021-04-30 Exercise or conversion : show line 3 in the form +1,354 $31.71 $42,935 19,202 D
2021-04-30 Sale : show line 4 in the form −4,166 $41.93 $174,680 15,036 D
Open-market sales · 4,166 sh · avg $41.93 · $174,680

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2021-04-30 Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) −1,042 25,000 D
2021-04-30 Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) −1,770 19,480 D
2021-04-30 Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) −1,354 46,042 D
Loading xslF345X03/doc4.xml…